Checking the safety of an eye drop on the eye's inner lining
This study tests whether an eye drop containing a numbing medicine (articaine) is safe for the inner lining of the eye (the corneal endothelium). The goal is to see if this medicine does not harm the cells that keep your eye clear and healthy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be generally healthy, with no significant medical or eye problems.
- You must not have had any eye surgery (either on the outside or inside of the eye) in the past 6 months.
- You must not have had an injection into the eye (called an intravitreal injection) in the past 14 days.
- You must be willing to sign a consent form to participate in this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new eye drop called PRO-190 to see if it's safe and comfortable for the eyes, comparing it to a common artificial tear (Systane Ultra). It is for healthy people and may help if you have dry or irritated eyes.
This Phase 1 study tests how safe and tolerable an investigational treatment (EO2002) is in adults having cataract surgery. It also looks at whether the treatment can be given without causing harmful effects in people with reduced cornea cell counts.
This study tests an experimental eye drop medication in healthy adults to see if it is safe and how the body handles it. It may help develop a new treatment for eye conditions.
This trial tests whether a new eye drop called BT01001 is safe for healthy adults. You may join if you have good overall and eye health, and do not use contact lenses or have chronic eye problems.
This trial tests a new eye drop called PAN-90806 in healthy people to see if it is safe and how the body handles it. Participants will receive the eye drops and be closely monitored.
This Phase 1 study tests whether EO2002 eye drops are safe and well tolerated in people with painful corneal swelling caused by the cornea’s inner lining not working well. It focuses on safety first, but your eye symptoms and vision may be monitored to see how you respond.
Hear when a new Healthy Cornea trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.